Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
2021-07-28
Original market date: See footnote 1
1987-12-31
Product name:
URISPAS TAB 200MG
DIN:
00728179 Electronic product monograph is not available
Company:
PALADIN PHARMA INC.
100 Blvd Alexis-Nihon, Suite 600
Saint-Laurent
Quebec
Canada
H4M 2P2
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
86:12.04
Anatomical Therapeutic Chemical (ATC): See footnote 4
G04BD02 FLAVOXATE
Active ingredient group (AIG) number:See footnote5
0115677001
Active ingredient(s) | Strength |
---|---|
FLAVOXATE HYDROCHLORIDE | 200 MG |